Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 7;9(1):342.
doi: 10.1186/s13287-018-1085-9.

Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes

Affiliations

Type I collagen deposition via osteoinduction ameliorates YAP/TAZ activity in 3D floating culture clumps of mesenchymal stem cell/extracellular matrix complexes

Nao Komatsu et al. Stem Cell Res Ther. .

Abstract

Background: Three-dimensional (3D) floating culture clumps of mesenchymal stem cell (MSC)/extracellular matrix (ECM) complexes (C-MSCs) consist of cells and self-produced ECM. Previous studies have demonstrated that C-MSCs can be transplanted into bony lesions without an artificial scaffold to induce bone regeneration. Moreover, osteoinductive medium (OIM)-treated C-MSCs (OIM-C-MSCs) have shown rapid and increased new bone formation in vivo. To apply OIM-C-MSCs for novel bone regenerative cell therapy, their cellular properties at the molecular level must be elucidated. The transcriptional co-activators yes-associated protein/transcriptional co-activator with PDZ-binding motif (YAP/TAZ) have been recognized as key players in the mechanotransduction cascade, controlling cell lineage commitment in MSCs. It is plausible that 3D C-MSCs/OIM-C-MSCs cultured in floating conditions could provide distinct microenvironments compared to conventional 2D culture systems and thereby induce unique mechanotransduction cascades. Therefore, this study investigated the YAP/TAZ activity in 3D-cultured C-MSCs/OIM-C-MSCs in floating conditions.

Methods: Human bone marrow-derived MSCs were cultured in growth medium supplemented with ascorbic acid. To obtain C-MSCs, confluent cells that had formed on the cellular sheet were scratched using a micropipette tip and were then torn off. The sheet was rolled to make round clumps of cells. Then, YAP/TAZ activity, filamentous actin (F-actin) integrity, collagen type I (COL1) production, and the differentiation potency in 3D floating culture C-MSCs/OIM-C-MSCs were analyzed.

Results: C-MSCs cultured in floating conditions lost their actin cytoskeleton to downregulate YAP/TAZ activity, which directed cells to undergo adipogenesis/chondrogenesis. OIM treatment induced abundant COL1 deposition, which facilitated Intβ1-dependent actin fiber formation and YAP/TAZ activity to elevate the expression levels of osteogenic master transcriptional factor runt-related transcription factor 2 (RUNX2) mRNA in C-MSCs. Importantly, elevation of YAP/TAZ activity via OIM was associated with COL1 deposition and F-actin integrity, suggesting a positive feedback loop in OIM-C-MSCs.

Conclusion: These findings suggest that OIM-C-MSCs, which form a unique microenvironment that maintains high YAP/TAZ activity, can serve as better candidates for bone regenerative cell therapy than C-MSCs.

Keywords: 3D culture; C-MSCs; F-actin; Mechanotransduction; YAP/TAZ.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Ethical approval for human subjects was obtained from the Independent Ethics Committee of Hiroshima University (reference number 422-2).

Consent for publication

Not applicable. This manuscript does not contain any individual person’s data.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
YAP and TAZ are downregulated in 3D-cultured C-MSCs. a Schematic image of C-MSC culture. Bar = 5 mm. bg C-MSCs were generated and maintained in growth medium (GM) for the indicated culture periods. b Upper panels indicate macroscopic images of C-MSCs. Lower panels show confocal immunofluorescence images of COL1 and nuclei in C-MSCs. Bar = 100 μm. c Confocal immunofluorescence images of YAP/TAZ (green), F-actin (red), and nuclei (blue) in C-MSCs. Bar = 20 μm. White boxes show enlarged images. d The graph summarizes the distribution of YAP/TAZ patterns. The patterns were classified as mainly nuclear (N > C), diffuse (N = C) and mainly cytoplasmic or undetectable (N < C or undetectable). e Immunoblotting for YAP/TAZ in C-MSCs. f, h Real-time PCR for YAP and TAZ (f) or YAP/TAZ target genes (h) in C-MSCs. Data were normalized to the values on day 0. Values represent means ± S.D. of three cultures (**p < 0.01). g Phos-tag-SDS-PAGE was used to show the phosphorylation levels of YAP/TAZ. Arrowheads indicate the position of unphosphorylated YAP/TAZ. Levels of total YAP/TAZ were analyzed by immunoblotting. All graphs and images are representative of three independent experiments
Fig. 2
Fig. 2
Three-dimensional floating culture C-MSCs can be directed towards adipogenesis/chondrogenesis but not osteogenesis due to reduced YAP/TAZ activity. ad C-MSCs were cultured in a OIM, b AIM, c CIM, or d dual medium for 5 days. Differentiation marker gene expression levels were analyzed by real-time PCR. Data were normalized to the values of C-MSCs maintained in GM. eg C-MSCs transfected with a constitutively active TAZ mutant (TAZS89A) or control plasmid were maintained in e OIM, f AIM, or g CIM for 5 days. Differentiation marker gene expression levels were analyzed by real-time PCR. Data were normalized to the values of C-MSCs transfected with control vector (cont). Values represent means ± S.D. of three cultures (**p < 0.01). All graphs are representative of three independent experiments
Fig. 3
Fig. 3
Osteoinductive medium facilitates F-actin formation and YAP/TAZ activity in C-MSCs. a, b C-MSCs were cultured in OIM for the indicated culture period. a Confocal immunofluorescence images of COL1 and nuclei. Bar = 100 μm. b Confocal immunofluorescence images of YAP/TAZ (green), F-actin (red), and nuclei (blue) in C-MSCs. Bar = 20 μm. White boxes show enlarged images. c The graph summarizes the distribution of YAP/TAZ localization patterns. The patterns were classified as mainly nuclear (N > C), diffuse (N = C), or mainly cytoplasmic or undetectable (N < C or undetectable). df C-MSCs: C-MSCs cultured in GM for 5 days. OIM-C-MSCs: C-MSCs cultured in OIM for 5 days. d Immunoblotting for YAP/TAZ. A rabbit anti-YAP/TAZ (D24E4) mAb (Cell Signaling) was used to detect both the YAP and TAZ proteins (middle panel). To show YAP expression more clearly, we also used a rabbit anti-YAP (D8H1X) mAb (upper panel). e Real-time PCR of YAP/TAZ target genes. Data were normalized to the values of C-MSCs. Values represent means ± S.D. of three cultures (**p < 0.01). f C-MSCs transfected with negative control or YAP and TAZ siRNAs were cultured in OIM for 5 days. RUNX2 expression levels were analyzed by real-time PCR. Data were normalized to the values of OIM-C-MSCs transfected with negative control siRNA. Values represent means ± S.D. of three cultures (**p < 0.01). All graphs and images are representative of three independent experiments
Fig. 4
Fig. 4
The effects of OIM components on COL1 production, F-actin integrity, and YAP/TAZ activity in C-MSCs. ac C-MSCs were cultured with GM (none) in the presence of β-glycerophosphate (Gly), ascorbic acid (AA), and/or dexamethasone (Dex) (Gly+AA, Gly+Dex, AA+Dex, and Gly+AA+Dex (equivalent to OIM)) for 5 days. a Confocal immunofluorescence images of COL1 (green) and nuclei (blue) in C-MSCs. Bar = 100 μm. b Confocal immunofluorescence images of YAP/TAZ (green), F-actin (red), and nuclei (blue) in C-MSCs. Bar = 20 μm. c The graph summarizes the distribution of YAP/TAZ patterns. The patterns were classified as mainly nuclear (N > C), diffuse (N = C), and mainly cytoplasmic or undetectable (N < C or undetectable)
Fig. 5
Fig. 5
OIM-induced YAP/TAZ activity in C-MSCs is due to actin cytoskeletal tension caused by Intβ1-ROCK signaling. aj C-MSCs: C-MSCs cultured with GM for 5 days. OIM-C-MSCs: C-MSCs cultured with OIM for 5 days. ae C-MSCs transfected with negative control or Intβ1 siRNAs were cultured with GM or OIM for 5 days. a Confocal immunofluorescence images of YAP/TAZ (green), F-actin (red), and nuclei (blue) in OIM-C-MSCs. Bar = 20 μm. White boxes show enlarged images. b The graph summarizes the distribution of YAP/TAZ localization patterns. The patterns were classified as mainly nuclear (N > C), diffuse (N = C), and mainly cytoplasmic or undetectable (N < C or undetectable). c Immunoblotting for YAP/TAZ in OIM-C-MSCs. A rabbit anti-YAP/TAZ (D24E4) mAb (Cell Signaling) was used to detect both the YAP and TAZ proteins (middle panel). To show YAP expression more clearly, we also used a rabbit anti-YAP (D8H1X) mAb (upper panel). d Real-time PCR analysis of YAP/TAZ target genes. Data were normalized to the values of control siRNA-transfected C-MSCs. Values represent means ± S.D. of three cultures (**p < 0.01). e RUNX2 expression levels in OIM-C-MSCs were analyzed by real-time PCR. Data were normalized to the values of OIM-C-MSCs transfected with negative control siRNA. Values represent means ± S.D. of three cultures (**p < 0.01). All graphs and images are representative of three independent experiments. fj C-MSCs or OIM-C-MSCs were cultured with or without a ROCK inhibitor (Y27632, 50 μM), the non-muscle myosin inhibitor blebbistatin (Blebbist., 50 μM), or an appropriate concentration of DMSO for 5 days. f Confocal immunofluorescence images of YAP/TAZ (green), F-actin (red), and nuclei (blue) in OIM-C-MSCs. Bar = 20 μm. White boxes show enlarged images. g The graph summarizes the distribution of YAP/TAZ localization patterns. The patterns were classified as mainly nuclear (N > C), diffuse (N = C), and mainly cytoplasmic or undetectable (N < C or undetectable). h Immunoblotting for YAP/TAZ in OIM-C-MSCs. A rabbit anti-YAP/TAZ (D24E4) mAb (Cell Signaling) was used to detect both the YAP and TAZ proteins (middle panel). To show YAP expression more clearly, we also used a rabbit anti-YAP (D8H1X) mAb (upper panel). i Real-time PCR analysis of YAP/TAZ target genes. Data were normalized to the values of C-MSCs treated with DMSO. Values represent means ± S.D. of three cultures (**p < 0.01). j RUNX2 expression levels in OIM-C-MSCs were analyzed by real-time PCR. Data were normalized to the values of OIM-C-MSCs treated with DMSO. Values represent means ± S.D. of three cultures (**p < 0.01). All graphs and images are representative of three independent experiments
Fig. 6
Fig. 6
YAP/TAZ activity is associated with COL1 synthesis and F-actin formation, generating a positive feedback loop in OIM-C-MSCs. (am) C-MSCs: C-MSCs cultured with GM for 5 days. OIM-C-MSCs: OIM-C-MSCs cultured with OIM for 5 days. ae C-MSCs transfected with negative control, YAP and TAZ, or Intβ1 siRNAs were cultured with OIM for 5 days. a, d COL1A1 mRNA expression levels were analyzed by real-time PCR. Data were normalized to the values of OIM-C-MSCs transfected with negative control siRNA. Values represent means ± S.D. of three cultures (**p < 0.01). b, e Confocal immunofluorescence images show COL1 (green) and nuclei (blue) in OIM-C-MSCs. Bar = 100 μm. c Confocal immunofluorescence images of YAP/TAZ (green), F-actin (red), and nuclei (blue) in OIM-C-MSCs. Bar = 20 μm. f, g OIM-C-MSCs were cultured with or without a ROCK inhibitor (Y27632, 50 μM), the non-muscle myosin inhibitor blebbistatin (Blebbist., 50 μM), or an appropriate concentration of DMSO for 5 days. f COL1A1 mRNA expression levels were analyzed by real-time PCR. Data were normalized to the values of C-MSCs treated with DMSO. Values represent means ± S.D. of three cultures (**p < 0.01). g Confocal immunofluorescence images show COL1 (green) and nuclei (blue) in C-MSCs. Bar = 100 μm. hl C-MSCs transfected with a constitutively active TAZ mutant (TAZS89A) or control plasmid were maintained in GM for 5 days. h COL1A1 mRNA expression levels were analyzed by real-time PCR. Data were normalized to the values of C-MSCs transfected with control vector (cont). Values represent means ± S.D. of three cultures (**p < 0.01). i Confocal immunofluorescence images show COL1 (green) and nuclei (blue) in C-MSCs. Bar = 100 μm. j Confocal immunofluorescence images of YAP/TAZ/TAZS89A (green), F-actin (red), and nuclei (blue) in C-MSCs. Bar = 20 μm. k Immunoblotting for YAP/TAZ in OIM-C-MSCs. A rabbit anti-YAP/TAZ (D24E4) mAb (Cell Signaling) was used to detect YAP, TAZ, and TAZS89A mutant proteins (middle panel). To show YAP expression more clearly, a rabbit anti-YAP (D8H1X) mAb was also used (upper panel). l Real-time PCR of YAP, TAZ, or YAP/TAZ target genes. Data were normalized to the values of C-MSCs transfected with a control vector (cont). Values represent means ± S.D. of three cultures (**p < 0.01)
Fig. 7
Fig. 7
Schematic summary of mechanotransduction cascade in C-MSCs and OIM-C-MSCs

Similar articles

Cited by

References

    1. Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 2017;6(12):2173–2185. doi: 10.1002/sctm.17-0129. - DOI - PMC - PubMed
    1. Bose S, Roy M, Bandyopadhyay A. Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 2012;30(10):546–554. doi: 10.1016/j.tibtech.2012.07.005. - DOI - PMC - PubMed
    1. Nagahara T, Yoshimatsu S, Shiba H, Kawaguchi H, Takeda K, Iwata T, Mizuno N, Fujita T, Kurihara H. Introduction of a mixture of beta-tricalcium phosphate into a complex of bone marrow mesenchymal stem cells and type I collagen can augment the volume of alveolar bone without impairing cementum regeneration. J Periodontol. 2015;86(3):456–464. doi: 10.1902/jop.2014.140384. - DOI - PubMed
    1. Kittaka M, Kajiya M, Shiba H, Takewaki M, Takeshita K, Khung R, Fujita T, Iwata T, Nguyen TQ, Ouhara K, et al. Clumps of a mesenchymal stromal cell/extracellular matrix complex can be a novel tissue engineering therapy for bone regeneration. Cytotherapy. 2015;17(7):860–873. doi: 10.1016/j.jcyt.2015.01.007. - DOI - PubMed
    1. Takeshita K, Motoike S, Kajiya M, Komatsu N, Takewaki M, Ouhara K, Iwata T, Takeda K, Mizuno N, Fujita T, et al. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration. Stem Cell Res Ther. 2017;8(1):101. doi: 10.1186/s13287-017-0550-1. - DOI - PMC - PubMed

Publication types

MeSH terms